When pharmaceutical and medical device manufacturers run into headaches, they often call Reed Smith.
The firm’s national products liability practice, largely led by California-based partners, represents companies such as Merck, Medtronic and GlaxoSmithKline. Medtronic turned to Reed Smith after it was hit with hundreds of suits alleging problems with offlabel use of a bone graft fusion device designed for degenerative disc disease. Reed Smith L.A. attorneys Michael Brown and Lisa Baird have shut down many of the claims by asserting federal preemption.
Brown also has led the successful defense of C.R. Bard over claims that its implantable blood filters can cause complications.
Download the .PDF to read more!